Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.33 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.33 |
| ▸ | PTGES | O14684 | 1/20 | 0.32 |
| ▸ | TSPO | P30536 | 1/20 | 0.30 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.30 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17904198 | 1.00 | KDM4E (0.38) | KDM4EATML3MBTL1PTGER4NPY5R | |
| SCHEMBL17829144 | 0.99 | KDM4E (0.38) | KDM4EATML3MBTL1PTGER4NPY5R | |
| SCHEMBL17904204 | 0.98 | KDM4E (0.37) | KDM4EATML3MBTL1PTGER4NPY5R | |
| SCHEMBL17904200 | 0.98 | KDM4E (0.37) | KDM4EATML3MBTL1PTGER4NPY5R | |
| SCHEMBL17828924 | 0.98 | KDM4E (0.37) | KDM4EATML3MBTL1PTGER4NPY5R | |
| SCHEMBL17904214 | 0.97 | KDM4E (0.36) | KDM4EATML3MBTL1PTGER4NPY5R | |
| SCHEMBL17904211 | 0.96 | KDM4E (0.35) | KDM4EATML3MBTL1PTGER4NPY5R | |
| SCHEMBL18058341 | 0.95 | L3MBTL1 (0.39) | KDM4EATML3MBTL1PTGER4NPY5R | |
| SCHEMBL17828941 | 0.95 | L3MBTL1 (0.39) | KDM4EATML3MBTL1HDAC4KMT2A | |
| SCHEMBL18058336 | 0.95 | L3MBTL1 (0.41) | KDM4EATML3MBTL1PTGER4NPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9508939-B2 | Compound and organic electroluminescent element produced using same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-11-29 | — | — | US | disclosed |
| US-9508939-B2 | Compound and organic electroluminescent element produced using same | IDEMITSU KOSAN CO., LTD. (JP) | 2016-11-29 | — | — | US | disclosed |
| US-20160172604-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2016-06-16 | — | — | US | disclosed |
| US-20160172604-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160172604-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME | L1CAM, LEF1, EML4 | KDM4E 2236/4885ATM 2921/4885L3MBTL1 271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.